MTOR Inhibitors in Older Adults

NCT06727305 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Aging

Interventions

DRUG: Sirolimus 0.5 Mg Oral Tablet
DRUG: Sirolimus 1Mg Oral Tablet
DRUG: Sirolimus 2 MG Oral Tablet
DRUG: Everolimus 0.5 MG Oral Tablet
DRUG: Everolimus 1 MG Oral Tablet
DRUG: Everolimus 2 MG Oral Tablet

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]